autoantibodies

  1. SNT Gatchaman

    Exploratory clinical and immunological changes following Tixagevimab/Cilgavimab administration in immunodeficient patients…, 2026, Seidel+

    Exploratory clinical and immunological changes following Tixagevimab/Cilgavimab administration in immunodeficient patients with SARS-CoV-2-associated ME/CFS and persistent circulating spike protein Seidel; Anft; Wiemers; Seibert; Bertram; Rosiewicz; Stervbo; Westhoff; Babel BACKGROUND...
  2. Chandelier

    Brain-binding auto-antibodies in subjects with and without post-COVID-syndrome after SARS-CoV-2 infection, 2026, Faraj et al.

    Brain-binding auto-antibodies in subjects with and without post-COVID-syndrome after SARS-CoV-2 infection Highlights Seroprevalence of brain binding autoantibodies is increased in the long-term after COVID-19 Post COVID Syndrome does not correlate with the prevalence of NMDAR1 autoantibodies...
  3. SNT Gatchaman

    Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitis, 2026, Tran et al.

    Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitis Chikungunya virus (CHIKV) infection is typically not life threatening but may, in rare cases, affect the central nervous system (CNS). In three cohorts of confirmed CHIKV...
  4. SNT Gatchaman

    Impact of immunoadsorption on autoantibodies and physical performance in post-COVID patients […] exploratory study of 18 participants, 2026, Wossidlo+

    Impact of immunoadsorption on autoantibodies and physical performance in post-COVID patients: a prospective exploratory study of 18 participants PURPOSE Autoantibodies against β-adrenergic and muscarinic acetylcholine receptors are said to play a role in the pathophysiology of post-COVID...
  5. Formerhuman

    David Putrino wants to trial Efgartigimod for a subgroup of patients with Long Covid

    At the Icahn School of Medicine at Mount Sinai, the neuroscientist and long COVID expert David Putrino is collecting blood samples from some of the patients who responded well to Vyvgart. He hopes the samples could enable better immune phenotyping so clinicians can predict whether a person with...
  6. SNT Gatchaman

    Trial Report Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial, 2026, Stortz et al.

    Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial BACKGROUND Post-Covid syndrome is a debilitating condition which may be caused and/or aggravated by autoantibodies. The current study aimed to determine whether autoantibody depletion...
  7. J

    Autoantibody landscapes in Long COVID with neurological symptoms show heterogeneity without a shared disease signature, 2026, Chakravarty et al

    Now published, see post #3. Preprint: Abstract Background: Neurological Long COVID (n-LC) includes persistent cognitive and autonomic symptoms after SARS-CoV-2 infection. Prior studies of post-COVID conditions have described diverse humoral autoreactivity, but findings are heterogeneous, and...
  8. ME/CFS Science Blog

    ME/CFS Science Blog article - Immune findings in ME/CFS

    Link to the article: https://mecfsscience.org/immune-findings-in-me-cfs/
  9. SNT Gatchaman

    Autoantibodies in long COVID in a black/mixed population compared with recovered and pre-pandemic controls, 2025, de Jesus Silva et al.

    Autoantibodies in long COVID in a black/mixed population compared with recovered and pre-pandemic controls INTRODUCTION Long COVID (LC), a clinical condition marked by persistent and new symptoms after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affects up to...
  10. forestglip

    Autonomic dysfunction and vasoregulation in Long COVID-19 are linked to anti-GPCR autoantibodies, 2025, Schmitz et al

    Autonomic dysfunction and vasoregulation in Long COVID-19 are linked to anti-GPCR autoantibodies [Line breaks added] Background SARS-CoV-2-triggered autoantibodies (AAB) targeting G protein-coupled receptors (GPCRs) have been suggested to contribute to the post-acute sequelae of COVID-19...
  11. Hutan

    Autoantibodies in patients with fibromyalgia syndrome, 2025, Seefried, Bardic, Grijalva Yepez et al

    Team from Germany Abstract The objective of this study was to assess the frequency of IgG autoantibodies in patients with fibromyalgia syndrome (FMS), to characterize their binding to dorsal root ganglion (DRG) neurons and glial cells, and to assess whether specific DRG binding patterns...
  12. SNT Gatchaman

    Aβ low threshold mechanoreceptors contribute to sensory abnormalities in fibromyalgia, 2025, Israel et al.

    Aβ low threshold mechanoreceptors contribute to sensory abnormalities in fibromyalgia Fibromyalgia syndrome (FM) is characterized by widespread pain and fatigue. People living with FM also experience tactile allodynia, cold-evoked pain, paraesthesia and dysaesthesia. There is evidence of small...
  13. SNT Gatchaman

    Preprint Autoantibodies mediate pain and sensory dysfunction in post-COVID syndrome, 2025, Bevan et al.

    Autoantibodies mediate pain and sensory dysfunction in post-COVID syndrome Pain and fatigue are common but poorly understood features of post-COVID Syndrome (PCS). To probe the mechanistic basis of these symptoms, we investigated sensory functions in patients with widespread pain attributed to...
  14. J

    Pathogenic IgG from [LC] patients with neurological sequelae triggers sensitive but not cognitive impairments upon transfer into mice, 2026, Mignolet+

    Now published, see post #4 Pathogenic IgG from long COVID patients with neurological sequelae triggers sensitive but not cognitive impairments upon transfer into mice Abstract Approximately 30% of long COVID patients still experience neurological symptoms (brain fog, pain, chronic fatigue)...
  15. forestglip

    Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalization, 2025, Netto et al

    Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalization Rebeca Linhares Abreu Netto, Catherine Chen, Victor Irungu Mwangi, Carlos Eduardo Padron de Morais, Mariana Simão Xavier, Luiz Gustavo Gardinassi, Emily Marie Eriksson, Nicholas...
  16. SNT Gatchaman

    Preprint A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunity, 2025, Slowikowski et al.

    A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunity The alpha-variant wave of the COVID-19 pandemic provided a unique opportunity to study, at single-cell resolution, how near-universal exposure to the same pathogen can lead to either effective or...
  17. forestglip

    Do self-perpetuating B lymphocytes drive human autoimmune disease?, 1999, Edwards et al

    Do self-perpetuating B lymphocytes drive human autoimmune disease? Jonathan C W Edwards, Geraldine Cambridge, Vikki M Abrahams Published: 1999 [Line breaks added] Abstract Normal immunological memory is thought to be underpinned by T lymphocytes. However, in rheumatoid arthritis there are...
  18. SNT Gatchaman

    Functional Autoantibodies Targeting G-Protein-Coupled Receptors and Their Clinical Phenotype in Patients with Long-COVID, 2025, Hofmann, Hohberger+

    Functional Autoantibodies Targeting G-Protein-Coupled Receptors and Their Clinical Phenotype in Patients with Long-COVID Long-COVID (LC) is characterized by diverse and persistent symptoms, potentially mirroring different molecular pathways. Recent data might offer that one of them is mediated...
  19. forestglip

    Long COVID is associated with female sex; Anti-NCAM1 autoantibodies are absent in patients with long COVID, 2025, Motokawa et al

    Long COVID is associated with female sex; Anti-NCAM1 autoantibodies are absent in patients with long COVID Yukiko Motokawa, Jun Sugihara, Tomoya Tateishi, Tadashi Hosoya, Shinsuke Yasuda, Yasunari Miyazaki, Hidehiko Takahashi, Hiroki Shiwaku [Line breaks added] Background Long COVID is a...
  20. V

    Fibromyalgia syndrome—am I an autoimmune condition?, 2025, Goebel

    This is disapointing… …"This implies that experience of trauma and distress might elicit a specific immune-biological response in genetically or otherwise (eg, past infection, toxicity, trauma) vulnerable individuals, which includes the production of harmful noninflammatory autoantibodies." …...
Back
Top Bottom